跳至主要内容
临床试验/TCTR20170704001
TCTR20170704001招募中3 期

Randomized study of high-dose (60-64 Gy) versus standard-dose (50 Gy) Intensity-Modulated Radiation Therapy (IMRT) for the trimodality therapy of patients with squamous cell carcinoma of thoracic esophagus.

Ratchadaphiseksomphot Endowment Fund0 个研究点目标入组 172 人开始时间: 2017年7月4日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
172

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • 1.Confirmed histopathologic diagnosis of primary (non-recurrent) squamous cell carcinoma of thoracic esophagus
  • 2.T2-T4b, N0-3, M0 (Appendix 2)
  • 3.Age 18-75 years
  • 4.Karnofsky performance scale 60-100
  • 5.Acceptable laboratory investigation: WBC ≥ 3,000/μl, platelets ≥ 100,000/μl; serum creatinine ≤ 1.6 mg/dl or creatinine clearance ≥ 60 ml/min using the following formula:
  • Estimated Creatinine Clearance = [140 †age (y)] x Body weight (kg) x 0.85 if female/ [72 x Serum creatinine (mg/dl)]
  • 6.Weight loss < 20%
  • 7.Dysphagia in any grade
  • 8.Signed study-specific informed consent form prior to study entry

排除标准

  • 1.Prior chest radiotherapy; prior systemic chemotherapy; prior major esophageal surgery.
  • 2.Patients with multiple primary carcinomas of the esophagus.
  • 3.Patients with TE fistula or metastatic disease (other than supraclavicular or celiac nodes).
  • 4.Pregnant or lactating women or men unable or unwilling to practice contraception.
  • 5.Patients with an uncontrolled diabetes (the blood sugar level was more than 180 mg/dL at the time of the PET scan), heart disease, hypertension, other uncontrolled serious medical or mental illnesses.
  • 6.Patients who are unable to comprehend the study requirements or who are not likely to comply with the study parameters.

研究者

发起方
Ratchadaphiseksomphot Endowment Fund

相似试验